New Liver-Targeted attack on stubborn colon cancer
NCT ID NCT06607458
Summary
This study is for people with advanced colorectal cancer that has spread mainly to the liver and is no longer responding to standard treatments. It aims to see if a procedure that delivers high-dose chemotherapy directly to the liver, followed by standard oral cancer drugs, works better and is safe compared to using the standard drugs alone. Researchers will measure how long the cancer in the liver is kept under control and monitor side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY METASTATIC COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
City of Hope
RECRUITINGDuarte, California, 91010, United States
-
Czech Republic - University Hospital
RECRUITINGPrague, Czechia
-
Helios Park-Klinikum Leipzig
RECRUITINGLeipzig, Germany
-
Hospital Clinic Barcelona
RECRUITINGBarcelona, Spain
-
Instiuto Europeo de Oncologia
RECRUITINGMilan, Italy
-
Moffitt Cancer Center
RECRUITINGTampa, Florida, 33612, United States
-
The University of Kansas Clinical Research Center
RECRUITINGFairway, Kansas, 66205, United States
-
UCLA Hematology/Oncology-Santa Monica
RECRUITINGSanta Monica, California, 90404, United States
Conditions
Explore the condition pages connected to this study.